902 F.3d 519
5th Cir.2018Background
- Whole Foods maintained an ESOP-style Company Stock Fund within its 401(k) Plan; Thomas Martone, a participant, sued three fiduciaries alleging breach of ERISA duties for allowing continued investment in allegedly overvalued Whole Foods stock.
- Martone alleged a systemic overcharging/weight-misstatement scheme revealed by multiple municipal investigations and press reports between 2014–2015, and that disclosures caused a material stock price decline in July 2015.
- He claimed defendants knew or should have known the stock was artificially inflated and took no protective action, causing loss to participants who held stock when the market corrected.
- Martone proposed three alternative fiduciary actions: (1) freeze/close the Company Stock Fund temporarily, (2) effect corrective public disclosure earlier, and (3) purchase a low-cost hedging product to offset Company Stock Fund exposure.
- The district court dismissed under Rule 12(b)(6) for failure to plead a plausible alternative action required by Fifth Third Bancorp v. Dudenhoeffer; the Fifth Circuit affirmed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Standing (injury-in-fact) to sue under ERISA for holding overvalued stock | Martone alleged he purchased and held Whole Foods stock during class period and suffered loss when truth emerged and price fell | Defendants argued holding without a realized-sale at a loss is insufficient | Held: Martone has standing; alleging post-disclosure market decline suffices at pleading stage (Dura does not require sale) |
| Whether plaintiff pleaded a plausible alternative fiduciary action consistent with securities laws (early public disclosure) | Earlier disclosure would have limited the eventual harsher correction; Plan was a net purchaser so earlier disclosure would benefit net buyers | Defendants: earlier disclosure risks spooking the market and could do more harm than good; investigation warranted delay; allegation of net purchaser is hindsight and uncertain | Held: Dismissed—general economic theory and net-purchaser allegation insufficient; a prudent fiduciary could conclude disclosure might do more harm than good (Dudenhoeffer/Whitley) |
| Whether freezing or closing the Company Stock Fund was a plausible alternative | A temporary freeze would protect participants from further purchases while avoiding forced disclosure | Defendants: freezing likely would depress price and could do more harm; not clearly preferable | Held: Not plausible—such actions likely lower stock and a prudent fiduciary could conclude harm outweighs benefits |
| Whether purchasing a low-cost hedging product was a plausible, non-disclosable alternative | Hedging product available to ESOPs could offset losses with minimal cost and not trigger securities-law disclosure | Defendants: purchasing a hedge may itself require participant notice or disclosure and could reveal risk, causing price drop | Held: Not plausible as pleaded—legal question whether such a hedge would be non-disclosable; plausible that it would risk disclosure and thus could do more harm than good |
Key Cases Cited
- Fifth Third Bancorp v. Dudenhoeffer, 134 S. Ct. 2459 (2014) (sets pleading standard for ERISA fiduciary claims based on inside or public information)
- Amgen Inc. v. Harris, 136 S. Ct. 758 (2016) (clarifies that plaintiffs must allege a prudent fiduciary "could not have concluded" an alternative would do more harm than good)
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standard—court need not accept legal conclusions)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility standard for complaints)
- Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005) (loss-causation principle in securities claims; decline after truth revealed is key)
- Whitley v. BP, PLC, 838 F.3d 523 (5th Cir. 2016) (applies Dudenhoeffer to reject disclosure/freeze alternatives where they likely would depress stock and could do more harm than good)